Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ocuphire Pharma Inc (OCUP)

Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocuphire Pharma Inc 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 USA

www.ocuphire.com P: 248-957-9024

Description:

Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.

Key Statistics

Overview:

Market Capitalization, $K 38,088
Enterprise Value, $K -12,412
Shares Outstanding, K 24,813
Annual Sales, $ 19,050 K
Annual Net Income, $ -9,990 K
Last Quarter Sales, $ 1,690 K
Last Quarter Net Income, $ -4,800 K
EBIT, $ -10,560 K
EBITDA, $ -10,550 K
60-Month Beta 0.33
% of Insider Shareholders 8.70%
% of Institutional Shareholders 14.97%
Float, K 22,654
% Float 91.30%
Short Volume Ratio 0.25

Growth:

1-Year Return -68.86%
3-Year Return -69.84%
5-Year Return -93.79%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 03/08/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.48
EPS Growth vs. Prev Qtr -184.00%
EPS Growth vs. Prev Year -113.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

OCUP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -22.30%
Return-on-Assets % -20.28%
Profit Margin % -52.44%
Debt/Equity 0.00
Price/Sales 1.99
Price/Cash Flow N/A
Price/Book 0.70
Book Value/Share 2.20
Interest Coverage -0.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar